Beijing Tiantan Biological Products Co., Ltd. (600161.SS)

CNY 20.69

(-1.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 14.18 Billion 12.94 Billion 11.57 Billion 7.54 Billion 6.31 Billion 5.06 Billion
Total Current Assets 7.56 Billion 7.27 Billion 7.54 Billion 4.65 Billion 4.04 Billion 3.43 Billion
Cash And Short Term Investments 4.55 Billion 3.71 Billion 4.32 Billion 1.74 Billion 1.41 Billion 1.24 Billion
Cash and Cash Equivalents 2.83 Billion 3.71 Billion 4.32 Billion 1.74 Billion 1.41 Billion 1.24 Billion
Short Term Investments 1.72 Billion 1.51 Billion -108.42 Million -105.5 Million -50.02 Million -15.41 Million
Net Receivables 133.21 Million 1.22 Billion 1.06 Billion 732.55 Million 681.78 Million 469.96 Million
Inventory 2.84 Billion 2.33 Billion 2.14 Billion 2.17 Billion 1.94 Billion 1.7 Billion
Other Current Assets 36.52 Million 273.67 Thousand 1.92 Million 3.6 Million 1.75 Million 4.43 Million
Total Non-Current Assets 6.61 Billion 5.66 Billion 4.03 Billion 2.88 Billion 2.26 Billion 1.63 Billion
Net PPE 5 Billion 4.05 Billion 2.63 Billion 1.99 Billion 1.56 Billion 986.87 Million
Good Will And Intangible Assets 1.22 Billion 1.1 Billion 829 Million 508.68 Million 445.87 Million 382.59 Million
Good Will 173.92 Million 173.92 Million 127.93 Million 115.01 Million 115.01 Million 95.52 Million
Intangible Assets 1.05 Billion 929.94 Million 701.07 Million 393.67 Million 330.85 Million 287.06 Million
Long-Term Investments 214.75 Million 217.88 Million 254.49 Million 227.09 Million 156.61 Million 97.25 Million
Tax Assets 46.73 Million 72.22 Million 67.01 Million 63.11 Million 53.78 Million 24.4 Million
Other Non Current Assets 128.68 Million 221.43 Million 250.8 Million 86.31 Million 51.76 Million 142.95 Million
Other Assets - 1.00 1.00 1.00 - 1.00
Total Liabilities 1.33 Billion 1.58 Billion 1.31 Billion 1.51 Billion 1.13 Billion 720.18 Million
Total Current Liabilities 1.27 Billion 1.15 Billion 809.57 Million 939.35 Million 651.94 Million 482.4 Million
Account Payables 74.39 Million 69.38 Million 73.7 Million 45.85 Million 49.93 Million 56.21 Million
Tax Payables 61.84 Million 137.42 Million 108.35 Million 85.52 Million 78.18 Million 87.22 Million
Short Term Debt 122.65 Million 123.8 Million 124.65 Million 326.37 Million 6.32 Million 13.13 Million
Deferred Revenue 357.25 Million 292.71 Million 604.88 Million 561.1 Million 276.02 Million 107.07 Million
Other Current Liabilities 725.31 Million 671.43 Million 6.32 Million 6.01 Million 319.65 Million 305.97 Million
Total Non Current Liabilities 54.5 Million 427.02 Million 501.19 Million 570.73 Million 485.1 Million 237.78 Million
Long-Term Debt 24.41 Million 279.36 Million 384.26 Million 474.59 Million 400.59 Million 230.78 Million
Deferred Revenue Non Current 99.56 Million 101.9 Million 92.68 Million 80.82 Million 73.54 Million 1.22 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -98.32 Million 4.1 Million 4.1 Million 4.16 Million 1.27 Million 2.54 Million
Other Liabilities -0.00 - - - - 1.00
Total Equity 12.75 Billion 11.35 Billion 10.26 Billion 6.03 Billion 5.17 Billion 4.34 Billion
Stock Holders Equity 9.82 Billion 8.79 Billion 8.05 Billion 4.51 Billion 3.93 Billion 3.37 Billion
Common Stock 1.64 Billion 1.64 Billion 1.37 Billion 1.25 Billion 1.04 Billion 871.13 Million
Retained Earnings 5.12 Billion 4.09 Billion 3.35 Billion 2.73 Billion 2.37 Billion 1.97 Billion
Accumulated other comprehensive income 358.51 Million 356.18 Million 350.37 Million 347.31 Million 345.43 Million 344.45 Million
Common Stock Equity 9.82 Billion 8.79 Billion 8.05 Billion 4.51 Billion 3.93 Billion 3.37 Billion
Capital Lease Obligation 24.41 Million 25.61 Million 18.01 Million 28.8 Million - -
Total Investments 1.93 Billion 146.06 Million 146.06 Million 121.59 Million 106.59 Million 81.83 Million
Total Debt 147.06 Million 403.17 Million 508.92 Million 800.96 Million 400.59 Million 230.78 Million
Net Debt -2.68 Billion -3.3 Billion -3.82 Billion -947.14 Million -1.01 Billion -1.01 Billion

Balance Sheet Charts